DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Germany
  • /
  • Insurance
Published
09 Jun 25
Updated
27 Aug 26
Views
106
Not Invested
TalanxTLX
TLX logo
Fair Value
€163
Share price27 Aug
€121.725.3% undervalued intrinsic discount
Loading
1Y8.47%
7D-0.57%

Global Wealth And Climate Trends Will Expand Insurance Horizons

AN
AnalystHighTarget
AnalystHighTarget

Analyst High Target compiles bullish analysts opinions to create narratives which represent one standard deviation above the consensus price target, using forecasted revenue and earnings figures, as well as the transcripts of earnings calls

Published
09 Jun 25
Updated
27 Aug 26
Views
106
Not Invested
Fair Value€163
Share price€121.7
25.3% undervalued intrinsic discount
Narrative
Updates9

Last Update 27 Aug 26

Fair value Increased 3.16%

TLX: Softening Market Exposure And Fresh Buy Ratings Will Drive Future Upside

The analyst price target for Talanx has moved from €158 to €163, with analysts pointing to recent Buy and Outperform ratings and viewing the current share price as an attractive entry point.

Analyst Commentary

Recent research on Talanx has highlighted a constructive tone, with bullish analysts pointing to valuation support and perceived upside at current share levels. The company has attracted fresh coverage and upgrades that frame the current price as appealing for investors assessing risk and reward.

Goldman Sachs initiated coverage of Talanx with a Buy rating and a €137 price target. Another large brokerage upgraded the stock to Outperform from Neutral with a €120 price target. These actions sit alongside the latest analyst price target of €163 and indicate growing confidence in the company’s execution and positioning.

Bullish Takeaways

  • Bullish analysts see current Talanx share levels as an attractive entry point, indicating that they view the stock as not fully reflecting their expectations for the business.
  • The move from Neutral to Outperform, combined with a €120 price target, indicates a more positive view on how Talanx is executing on its plans and managing its portfolio.
  • Fresh coverage from Goldman Sachs with a €137 price target provides another supportive reference point for valuation and reinforces interest from larger institutional research desks.
  • The current analyst price target of €163, set above the earlier referenced targets, represents a more optimistic stance on what Talanx could be worth if it continues to deliver against analysts’ expectations.

What’s in the News for Talanx

  • No recent Talanx specific news stories were provided in the primary source feed as of 26 August 2026.
  • No relevant periodical coverage for Talanx was included in the secondary sources.
  • No key development items were supplied for Talanx in the referenced datasets.

Valuation Changes for Talanx

  • Fair Value has risen slightly from €158 to €163, a move of around 3%.
  • Discount Rate has increased modestly from 5.26% to 5.41%.
  • € Revenue Growth assumption has risen from about 9.16% to about 12.19%.
  • Net Profit Margin estimate has eased from roughly 5.83% to roughly 5.40%.
  • Future P/E has moved higher from about 13.76x to about 15.26x.
Read more
2 viewsusers have viewed this narrative update

Key Takeaways

  • Outperformance driven by successful acquisitions, digitalization, and strong risk buffers positions Talanx for structural earnings growth and net margin stability.
  • Diversified global presence and disciplined underwriting enable ongoing margin expansion, revenue growth, and resilience to market volatility.
  • Rising climate risks, market softening, digital lag, and domestic weakness threaten profitability and growth while limited investment flexibility hampers future earnings power.

Catalysts

About Talanx
    Provides insurance and reinsurance products and services worldwide.
What are the underlying business or industry changes driving this perspective?
  • Analyst consensus acknowledges strong growth and profitability in International markets, but recent performance-driven by robust technical results, successful integration of LatAm acquisitions and the Polish minority buyout-suggests Talanx is outperforming expectations, with visible momentum setting up for structural earnings outperformance.
  • While the consensus recognizes Corporate & Specialty's disciplined underwriting and strong combined ratio, actual results have shown not just resilience but improving combined ratios and double-digit organic and bottom-line growth, indicating further upside to margins and returns on equity as the segment benefits from firm pricing and global commercial line expansion.
  • The company's exceptionally strong and growing solvency and reserve buffers, validated by external actuarial review, position Talanx as a highly trusted partner in a world of elevated systemic risks, supporting lower funding costs, potential rating upgrades, and long-term net margin stability.
  • With insurance demand rising globally due to increasing wealth and climate-driven risk, Talanx's diversification across primary insurance, specialty lines, and reinsurance places it at the center of long-run premium volume growth, supporting consistent revenue expansion irrespective of near-term volatility.
  • Talanx's accelerated digitalization-including automation of underwriting and claims-combined with strong cash remittances from stable segments such as Retail Germany, will enable ongoing cost ratio improvements and capital deployment into high-growth, high-margin business lines, further enhancing group earnings and future dividend growth.
Talanx Earnings and Revenue Growth

Talanx Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • This narrative explores a more optimistic perspective on Talanx compared to the consensus, based on a Fair Value that aligns with the bullish cohort of analysts.
  • The bullish analysts are assuming Talanx's revenue will grow by 12.2% annually over the next 3 years.
  • The bullish analysts assume that profit margins will shrink from 6.1% today to 5.4% in 3 years time.
  • The bullish analysts expect earnings to reach €3.2 billion (and earnings per share of €12.55) by about August 2029, up from €2.6 billion today. The analysts are largely in agreement about this estimate.
  • In order for the above numbers to justify the price target of the more bullish analyst cohort, the company would need to trade at a PE ratio of 15.3x on those 2029 earnings, up from 12.3x today. This future PE is greater than the current PE for the GB Insurance industry at 11.8x.
  • The bullish analysts expect the number of shares outstanding to grow by 0.17% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 5.41%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • High exposure to climate change and extreme weather events, evidenced by the €880 million large loss burden from California wildfires in just one quarter, poses increasing risks to underwriting profit and group net income as such events are projected to increase in frequency due to secular climate trends.
  • Softening in specialty and certain international insurance markets, as acknowledged in the text, could lead to rate increases not keeping pace with claims inflation, compressing underwriting margins and eventually reducing segment earnings.
  • The ongoing digital transformation challenges, including the lack of explicit mention of significant IT modernization or insurtech initiatives, leaves Talanx vulnerable to rising expense ratios and lost market share to more agile competitors, negatively impacting cost efficiency and long-term revenue growth.
  • Structural decline in Retail Germany business, with a 6% drop in insurance revenues following the end of the bancassurance agreement with TARGOBANK and an expected double-digit decline in the life business insurance service result, threatens the stability of both top-line revenues and segment profitability in a key domestic market.
  • Sustained low yields and high allocation to traditional fixed income investments (over 80% of assets in bonds) may limit future investment income, especially if interest rates decline or remain volatile, ultimately constraining net margins and eroding group earnings power.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The assumed bullish price target for Talanx is €163.0, which represents up to two standard deviations above the consensus price target of €128.43. This valuation is based on what can be assumed as the expectations of Talanx's future earnings growth, profit margins and other risk factors from analysts on the bullish end of the spectrum.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €163.0, and the most bearish reporting a price target of just €94.0.
  • In order for you to agree with the more bullish analyst cohort, you'd need to believe that by 2029, revenues will be €60.0 billion, earnings will come to €3.2 billion, and it would be trading on a PE ratio of 15.3x, assuming you use a discount rate of 5.4%.
  • Given the current share price of €124.0, the analyst price target of €163.0 is 23.9% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Talanx?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Comments

0 comments

Disclaimer

AnalystHighTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystHighTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystHighTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

TLX logo
Talanx
3.4% undervalued intrinsic discount

Future Growth May Face Challenges, But Diversification Could Provide Stability

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 13 Aug
Read Narrative
TLX logo
Talanx
29.5% overvalued intrinsic discount

Rising Climate Hazards And Digital Disruption Will Erode Insurer Resilience

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 15 Jul
Read Narrative

Fair Value vs Share Price

€163
vs €121.725.3% undervalued intrinsic discount
PastFuture060b2015201820212024202620272029Revenue €60.0bEarnings €3.2b
12.2%
Revenue growth
5.4%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Talanx

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Undervalued established dividend payer.

Market cap€31.4b
PB2.2x
Estimated Growth8.3%
Dividend Yield3.0%
Full analysis

CEO & management

Torsten Leue
CEO
5.1yrs
CEO Tenure

Provides insurance and reinsurance products and services worldwide.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide